EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression

Léa Pechtimaldjian iD, Marie-Laure Jullié, Chloé Rousson iD, Faiza Laanani iD, Julie Clachet iD, Yamina Idrissi, Maya Loot, Muriel Cario-Andre iD, Sorilla Prey iD, Alain Taieb iD, Christine Leauté-Labrèze, Thomas Mathivet iD und 1 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2526271123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Léa Pechtimaldjian und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France. Hauptthemen laut MEDLINE: Telocytes, C-Reactive Protein, Serum Amyloid P-Component, Hemangioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conseil Régional Aquitaine (Région Nouvelle-Aquitaine).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The natural course of infantile hemangioma (IH), a benign vascular infantile tumor, is marked by the initial rapid proliferation of dystrophic capillaries, followed by a regression phase, which is either spontaneous or induced by the first line treatment propranolol. Although endothelial cells have been at the center of most studies, the role of stromal cells in this vascular remodeling has remained unclear. Telocytes, which are stromal cells that may be targeted by propranolol, are involved in tissue organization and angiogenesis, suggesting their role in vascular remodeling during the regression of IH. To assess changes in vascular architecture of IH and the role of telocytes, we used Skin-iDISCO + 3-Dimensions (3D) sample imaging and in vitro models with patient-derived telocytes. Perivascular telocytes exhibited increased dendricity during regression, indicating their activation. Telocytes secretome profiling revealed a complex inhibitory program, with pentraxin 3 (PTX3) emerging as a central effector. 3D multicellular disease models demonstrated a paracrine effect blocking endothelial fibroblast growth factor receptors (FGFR) signaling via FGF2–PTX3 interaction, thereby strongly regulating endothelial proliferation, sprouting, and activation. In vitro mechanistic study and collagen IV staining analysis revealed that vascular regression is at least partially due to vascular pruning. These findings highlight the pivotal role of telocytes in orchestrating vascular remodeling during IH regression, opening therapeutic perspectives for inducing vascular normalization in pathological angiogenesis, including cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelocytesC-Reactive ProteinSerum Amyloid P-ComponentHemangiomaVascular RemodelingHumansPentraxinsPropranololFibroblast Growth Factor 2Neovascularization, PathologicInfantSignal TransductionEndothelial Cells

Stichwörter der Autor:innen

FGFR signalingangiogenesishemangiomatelocytetumor vasculature

Substanzen

PentraxinsC-Reactive ProteinSerum Amyloid P-ComponentPropranololFibroblast Growth Factor 2

Autor:innen und Institutionen

  • University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.
  • Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.
  • Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.
  • Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.
  • Aquiderm, Bordeaux F-33000, France.
  • Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.

ORCID-Profile: Léa Pechtimaldjian, Chloé Rousson, Faiza Laanani, Julie Clachet, Muriel Cario-Andre, Sorilla Prey, Alain Taieb, Thomas Mathivet, François Moisan

Förderung

  • Conseil Régional Aquitaine (Région Nouvelle-Aquitaine)

Zitieren

APA

Pechtimaldjian, L., Jullié, M. L., Rousson, C., Laanani, F., Clachet, J., Idrissi, Y., Loot, M., Cario-Andre, M., Prey, S., Taieb, A., Leauté-Labrèze, C., Mathivet, T., & Moisan, F. (2026). Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2526271123

Vancouver

Pechtimaldjian L, Jullié ML, Rousson C, Laanani F, Clachet J, Idrissi Y, et al. Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2526271123

BibTeX
@article{Pechtimaldjian2026,
  author = {Pechtimaldjian, Léa and Jullié, Marie-Laure and Rousson, Chloé and Laanani, Faiza and Clachet, Julie and Idrissi, Yamina and Loot, Maya and Cario-Andre, Muriel and Prey, Sorilla and Taieb, Alain and Leauté-Labrèze, Christine and Mathivet, Thomas and Moisan, François},
  title = {Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2526271123}
}
Kostenlos starten →